Passage Bio, Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 6.
AI score 6 (80% interval 5–8) · evidence grade D · US · Pharma / Chemicals
Stated reason: As part of its previously announced efforts to review strategic alternatives to maximize shareholder value, on April 28, 2026, Passage Bio, Inc. (the “ Company ”) announced a restructuring of its workforce (the “ Restructuring Plan ”) to decrease its operating expenses by reducing the workforce by approximately 75%. The implementation of the Restructuring Plan should be substantially complete in the second and third …
Why 6: Cost-cutting / efficiency · Drivers: industry AI exposure +0.5, role AI exposure +0.1
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.653, industry exposure 0.712, AI investment 0.0, contrary 0.0 · typical Health Care & Pharma roles (no roles named)
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
